Axel Schörling

Chief Executive Officer at EQL PHARMA AB

Net worth: 1 M $ as of 30/05/2026

40 year

9 connections

Consumer Services

Process Industries

Commercial Services

Profile

Axel Schörling is President & Chief Executive Officer at EQL Pharma AB since 2022 and Independent Director at Gasporox AB since 2023.
Formerly, Mr. Schörling was Director-Business Controlling at Perstorp AB. Mr. Schörling graduated from Chalmers University of Technology and Handelshögskolan i Göteborg.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
EQL PHARMA AB 1.36%	26/03/2026	401,445 ( 1.36% )	1 M $	30/05/2026

Axel Schörling active positions

Companies	Position	Start
EQL PHARMA AB	Chief Executive Officer	16/08/2022
GASPOROX AB	Director/Board Member	31/12/2022

All active positions of Axel Schörling

Former positions of Axel Schörling

Companies	Position	End
PERSTORP HOLDING AB (PUBL.)	Corporate Officer/Principal	-

See the detail of Axel Schörling's experience

Training of Axel Schörling

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Axel Schörling's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Perstorp AB Perstorp AB Chemicals: SpecialtyProcess Industries Manufactures and supplies specialty chemicals	Process Industries
Chalmers University of Technology Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Gasporox AB Gasporox AB Miscellaneous Commercial ServicesCommercial Services Provides laser technology and aims to benefits from non-intrusive diode laser spectroscopy technology	Commercial Services
Handelshögskolan i Göteborg Handelshögskolan i Göteborg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
EQL Pharma AB EQL Pharma AB Pharmaceuticals: GenericHealth Technology Manufactures and distributes generic and specialty pharmaceutical products	Health Technology